Tower Research Capital LLC (TRC) - LANTERN PHARMA INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of LANTERN PHARMA INC
ValueSharesWeighting
Q3 2023$6,332
-52.0%
1,857
-20.6%
0.00%
Q2 2023$13,192
+131820.0%
2,339
+10.5%
0.00%
Q1 2023$102,117
+7460.7%
0.00%
Q4 2022$0
-100.0%
28
-99.3%
0.00%
Q3 2022$19,000
+216.7%
3,817
+238.7%
0.00%
Q2 2022$6,0000.0%1,127
+45.8%
0.00%
Q1 2022$6,000
-53.8%
773
-52.0%
0.00%
Q4 2021$13,000
+116.7%
1,612
+204.2%
0.00%
Q3 2021$6,000
+20.0%
530
+50.6%
0.00%
Q2 2021$5,000
+400.0%
352
+467.7%
0.00%
Q1 2021$1,000
-90.9%
62
-89.5%
0.00%
Q4 2020$11,000
-15.4%
593
-16.4%
0.00%
Q3 2020$13,000
+550.0%
709
+317.1%
0.00%
Q2 2020$2,0001700.00%
Other shareholders
LANTERN PHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
SANDERS MORRIS HARRIS LLC 384,228$2,747,0000.54%
CM Management, LLC 33,765$241,0000.20%
WOLFF WIESE MAGANA LLC 36,155$259,0000.17%
Redmond Asset Management, LLC 49,793$356,0000.11%
CARLSON CAPITAL L P 167,300$1,196,0000.08%
NewEdge Advisors, LLC 169,771$1,214,0000.02%
Sigma Planning Corp 17,600$126,0000.00%
Spire Wealth Management 4,050$29,0000.00%
WELLS FARGO & COMPANY/MN 3,558$25,0000.00%
NORTHERN TRUST CORP 12,629$90,0000.00%
View complete list of LANTERN PHARMA INC shareholders